Ophthalmology
Upneeq Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Upneeq® (oxymetazoline hydrochloride ophthalmic solution 0.1%).
Upneeq® (oxymetazoline hydrochloride ophthalmic solution) is a prescription eye drop indicated for the treatment of acquired blepharoptosis, also known as low-lying eyelid, in adults. It is administered once daily to the affected eye and works by stimulating muscles responsible for eyelid elevation. Upneeq® may be prescribed to help improve the appearance and function of the upper eyelid.
Built to help reduce friction around treatment access & patient care.
Request Upneeq® (oxymetazoline hydrochloride ophthalmic solution 0.1%) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Upneeq Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Upneeq is a prescription ophthalmic solution used to raise the upper eyelid in acquired ptosis.
Upneeq may be prescribed for acquired blepharoptosis in adults.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.